Hepatitis B virus infection is associated with gastric cancer in China: An endemic area of both diseases

British Journal of Cancer

Volumn 112, Issue 7, 2015, Pages 1283-1290

  Wei, X L ^a   Qiu, M Z ^a   Jin, Y ^a   Huang, Y X ^b   Wang, R Y ^b   Chen, W W ^a   Wang, D S ^a   Wang, F ^a   Luo, H Y ^a   Zhang, D S ^a   Wang, F H ^a   Li, Y H ^a   Xu, R H ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

ABO blood group; Gastric cancer; Hepatitis B virus; Risk factor

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; BLOOD GROUP ABO SYSTEM;

ADULT; AGE; ARTICLE; BLOOD GROUP A; CANCER EPIDEMIOLOGY; CANCER PATIENT; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ENDEMIC DISEASE; EXPLORATORY RESEARCH; FAMILY HISTORY; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX RATIO; STOMACH CANCER; BLOOD; BLOOD GROUP ABO SYSTEM; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; ISOLATION AND PURIFICATION; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; STOMACH NEOPLASMS; VIROLOGY;

ABO BLOOD-GROUP SYSTEM; CASE-CONTROL STUDIES; CHINA; ENDEMIC DISEASES; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84938547480     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.406     Document Type: Article

References (47)

1. Allain JP (2004) Occult hepatitis B virus infection. Transfus Clin Biol 11: 18-25.
2. Allain JP, Mihaljevic I, Gonzalez-Fraile MI, Gubbe K, Holm-Harritshoj L, Garcia JM, Brojer E, Erikstrup C, Saniewski M, Wernish L, Bianco L, Ullum H, Candotti D, Lelie N, Gerlich WH, Chudy M (2013) Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion 53: 1405-1415.
3. Arzumanyan A, Reis HM, Feitelson MA (2013) Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer 13: 123-135.
4. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P (2001) Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely 'occult'? Hepatology 34: 194-203.
5. Cardoso C, Alves AL, Augusto F, Freire R, Quintana C, Goncalves M, Oliveira AP (2013) Occult hepatitis B infection in Portuguese patients with chronic hepatitis C liver disease: prevalence and clinical significance. Eur J Gastroenterol Hepatol 25: 142-146.
6. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73.
7. Chen NL, Bai L, Deng T, Zhang C, Kong QY, Chen H (2004) Expression of hepatitis B virus antigen and Helicobacter pylori infection in gastric mucosa of patients with chronic liver disease. Hepatobiliary Pancreat Dis Int 3: 223-225.
8. Chen Y, Qian F, Yuan Q, Li X, Wu W, Guo X, Li L (2011) Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs. J Clin Virol 52: 198-203.
9. Correa P, Fox J, Fontham E, Ruiz B, Lin YP, Zavala D, Taylor N, Mackinley D, de Lima E, Portilla H (1990) Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 66: 2569-2574.
10. Dehesa-Violante M, Nunez-Nateras R (2007) Epidemiology of hepatitis virus B and C. Arch Med Res 38: 606-611.
11. Dejean A, Lugassy C, Zafrani S, Tiollais P, Brechot C (1984) Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. J Gen Virol 65(Pt 3): 651-655.
12. Engels EA, Cho ER, Jee SH (2010) Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol 11: 827-834.
13. Gonzalez CA, Sala N, Capella G (2002) Genetic susceptibility and gastric cancer risk. Int J Cancer 100: 249-260.
14. Hassan MM, Li D, El-Deeb AS, Wolff RA, Bondy ML, Davila M, Abbruzzese JL (2008) Association between hepatitis B virus and pancreatic cancer. J Clin Oncol 26: 4557-4562.
15. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
16. Kai K, Miyoshi A, Kitahara K, Masuda M, Takase Y, Miyazaki K, Noshiro H, Tokunaga O (2012) Analysis of extrahepatic multiple primary malignancies in patients with hepatocellular carcinoma according to viral infection status. Int J Hepatol 2012: 495950.
17. Kim Y, Shin A, Gwack J, Ko KP, Kim CS, Park SK, Hong YC, Kang D, Yoo KY (2009) Epstein-Barr virus antibody level and gastric cancer risk in Korea: a nested case-control study. Br J Cancer 101: 526-529.
18. Kirchner GI, Beil W, Bleck JS, Manns MP, Wagner S (2011) Prevalence of Helicobacter pylori and occurrence of gastroduodenal lesions in patients with liver cirrhosis. Int J Clin Exp Med 4: 26-31.
19. Lada O, Benhamou Y, Poynard T, Thibault V (2006) Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of 'a' determinant variants. J Virol 80: 2968-2975.
20. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, Lunet N (2008) Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 19: 689-701.
21. Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ (2013a) Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. Hepatology 58: 546-554.
22. Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ (2013b) Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. Hepatology 58: 546-554.
23. Liu W, Hu T, Wang X, Chen Y, Huang M, Yuan C, Guan M (2012) Coexistence of hepatitis B surface antigen and anti-HBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region. Arch Virol 157: 627-634.
24. Loh M, Koh KX, Yeo BH, Song CM, Chia KS, Zhu F, Yeoh KG, Hill J, Iacopetta B, Soong R (2009) Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur J Cancer 45: 2562-2568.
25. Lu FM, Li T, Liu S, Zhuang H (2010) Epidemiology and prevention of hepatitis B virus infection in China. J Viral Hepat 17(Suppl 1): 4-9.
26. Mason A, Wick M, White H, Perrillo R (1993) Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology 18: 781-789.
27. Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR, Barbosa LH, Nemo GJ (1995) Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 35: 5-12.
28. Niwa T, Tsukamoto T, Toyoda T, Mori A, Tanaka H, Maekita T, Ichinose M, Tatematsu M, Ushijima T (2010) Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res 70: 1430-1440.
29. Norat T, Aune D, Chan D, Romaguera D (2014) Fruits and Vegetables: updating the epidemiologic evidence for the WCRF/AICR lifestyle recommendations for cancer prevention. Cancer Treat Res 159: 35-50.
30. Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni W, Nalpas B, Franco D, Wands J, Kew M, Pisi E, Tiollais P, Brechot C (1990) Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 323: 80-85.
31. Peleteiro B, Lopes C, Figueiredo C, Lunet N (2011) Salt intake and gastric cancer risk according to Helicobacter pylori infection, smoking, tumour site and histological type. Br J Cancer 104: 198-207.
32. Sadjadi A, Derakhshan MH, Yazdanbod A, Boreiri M, Parsaeian M, Babaei M, Alimohammadian M, Samadi F, Etemadi A, Pourfarzi F, Ahmadi E, Delavari A, Islami F, Farzadfar F, Sotoudeh M, Nikmanesh A, Alizadeh BZ, de Bock GH, Malekzadeh R (2014) Neglected role of hookah and opium in gastric carcinogenesis: A cohort study on risk factors and attributable fractions. Int J Cancer 134: 181-188.
33. Seo SI, Choi HS, Choi BY, Kim HS, Kim HY, Jang MK (2014) Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study. J Med Virol 86(1): 124-130.
34. Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Islami F, Pourshams A, Pawlita M, Boffetta P, Dawsey SM, Abnet CC, Kamangar F (2013) Opium: an emerging risk factor for gastric adenocarcinoma. Int J Cancer 133: 455-461.
35. Squadrito G, Cacciola I, Alibrandi A, Pollicino T, Raimondo G (2013) Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C. J Hepatol 59: 696-700.
36. Tan YJ (2011) Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J Gastroenterol 17: 4853-4857.
37. Tian Y, Yang W, Song J, Wu Y, Ni B (2013) Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol Cell Biol 33: 2810-2816.
38. Tramacere I, Negri E, Pelucchi C, Bagnardi V, Rota M, Scotti L, Islami F, Corrao G, La Vecchia C, Boffetta P (2012) A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol 23: 28-36.
39. Wang DS, Chen DL, Ren C, Wang ZQ, Qiu MZ, Luo HY, Zhang DS, Wang FH, Li YH, Xu RH (2012) ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer 131: 461-468.
40. Wang Z, Liu L, Ji J, Zhang J, Yan M, Zhang J, Liu B, Zhu Z, Yu Y (2012) ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int J Mol Sci 13: 13308-13321.
41. Yaghoobi M, Bijarchi R, Narod SA (2010) Family history and the risk of gastric cancer. Br J Cancer 102: 237-242.
42. Yoon JM, Son KY, Eom CS, Durrance D, Park SM (2013) Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis. World J Gastroenterol 19: 936-945.
43. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE (1990) Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 82: 1038-1041.
44. Yuan XY, Wang MY, Wang XY, Chang AY, Li J (2013) Non-detection of Epstein-Barr virus and Human Papillomavirus in a region of high gastric cancer risk indicates a lack of a role for these viruses in gastric carcinomas. Genet Mol Biol 36: 183-184.
45. Zhang JM, Xu Y, Wang XY, Yin YK, Wu XH, Weng XH, Lu M (2007) Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Clin Infect Dis 44: 1161-1169.
46. Zhou Y, Zhou Q, Lin Q, Chen R, Gong Y, Liu Y, Yu M, Zeng B, Li K, Chen R, Li Z (2013) Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism. Int J Cancer 133: 1867-1875.
47. Zullo A, Romiti A, Tomao S, Hassan C, Rinaldi V, Giustini M, Morini S, Taggi F (2003) Gastric cancer prevalence in patients with liver cirrhosis. Eur J Cancer Prev 12: 179-182.